[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Life Sciences Market Research Reports & Industry Analysis

“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.

The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.

A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.

Publications found: 255,120
Sort by:

Trigeminal Neuralgia - Pipeline Review, H1 2018

US$ 2,000.00

... . The Trigeminal Neuralgia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Trigeminal Neuralgia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 54 pages

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H1 2018

US$ 3,500.00

... Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 45 pages

C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) development landscape Develop ...

February 2018 60 pages

Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 (Carcinoembryonic Antigen or CEA or Meconium Antigen 100 or CD66e or CEACAM5) development landscape Develop and ...

February 2018 54 pages

Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) development landscape Develop and design ...

February 2018 113 pages

Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2018

US$ 2,000.00

... . The Bacillary Dysentery (Shigellosis) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacillary Dysentery (Shigellosis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

February 2018 43 pages

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) development landscape Develop ...

February 2018 77 pages

C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) targeted therapeutics development with ...

February 2018 104 pages

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews key players involved in Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A (Serine/Threonine Kinase MNB or MNB/DYRK Protein Kinase or Dual specificity YAK1 Related Kinase or HP86 or Protein Kinase Minibrain Homolog or DYRK1A or EC 2.7.12.1) targeted therapeutics development with respective ...

February 2018 35 pages

E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) - Pipeline Review, H1 2018

US$ 3,500.00

... /Universities. It also reviews key players involved in E3 Ubiquitin Protein Ligase XIAP (Baculoviral IAP Repeat Containing Protein 4 or IAP Like Protein or Inhibitor Of Apoptosis Protein 3 or X Linked Inhibitor Of Apoptosis Protein or XIAP or EC 6.3.2.) targeted therapeutics development with respective active ...

February 2018 74 pages

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H1 2018

US$ 3,500.00

... Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 59 pages

Human Papillomavirus Protein E7 (E7) - Pipeline Review, H1 2018

US$ 3,500.00

... Human Papillomavirus Protein E7 (E7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 120 pages

Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) development landscape Develop ...

February 2018 40 pages

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H1 2018

US$ 3,500.00

... Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 51 pages

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 49 pages

Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 55 pages

Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 3 (GPRC1C or MGLUR3 or GRM3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 46 pages

Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

February 2018 79 pages

Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) development landscape ...

February 2018 54 pages

Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) development landscape Develop ...

February 2018 90 pages

Hypoparathyroidism: Drug Development Pipeline Study, H1 2018

US$ 806.00

... that impact the Hypoparathyroidism industry. Excerpts from- “Hypoparathyroidism- Drug Development Pipeline Study”: Hypoparathyroidism pipeline comprises of 6 drugs under development as of February 2018. Of these, 3 drugs are in Phase 1 and 1 drug is in phase 2. Further, 2 drugs remain in Pre ...

February 2018 32 pages

Impetigo: Drug Development Pipeline Study, H1 2018

US$ 806.00

... the Impetigo industry. Excerpts from- “Impetigo- Drug Development Pipeline Study”: Impetigo pipeline comprises of 4 drugs under development as of February 2018. Of these, 2 drugs are in Phase 2 and 1 drug is in phase 2/3. Further, 1 drug is in Pre-Clinical Stage. No drugs have ...

February 2018 22 pages

Pontine Glioma (DIPG):Drug Development Pipeline Study, H1 2018

US$ 806.00

... Diffuse Intrinsic Pontine Glioma (DIPG) industry. Excerpts from- “Diffuse Intrinsic Pontine Glioma (DIPG)- Drug Development Pipeline Study”: Pontine Glioma pipeline comprises of 24 drugs under development as of February 2018. Of these, 6 drugs are in Phase 1 and 3 drugs are in phase ...

February 2018 65 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Epileptic Seizure Monitor Alarm System Market 2018 Forecast to 2023

US$ 4,880.00

... the Epileptic Seizure Monitor Alarm System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

February 2018 108 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Endoscopy Video Processors Market 2018 Forecast to 2023

US$ 4,880.00

... focuses on the Endoscopy Video Processors in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

February 2018 105 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) fNIRS Brain Imaging System Market 2018 Forecast to 2023

US$ 4,880.00

... on the fNIRS Brain Imaging System in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

February 2018 107 pages

North America Over the Counter Drugs Market - Forecasts from 2018 to 2023

US$ 3,200.00

... help the clients in gaining faster and efficient understanding of the North America over the counter drugs market. Major industry players profiled as part of the ... , Pfizer Inc., and Bayer AG others. Segmentation The North America over the counter drugs market has been analyzed through following segments: By ...

February 2018 78 pages

Augmented Reality (AR) and Virtual Reality (VR) Market in Healthcare - Global Outlook and Forecast 2018-2023

US$ 3,500.00

... intelligence (AI), point-of-care diagnostics (POC), virtual reality (VR), augmented reality (AR), biosensors and trackers, convenient care, ... pain distraction VR assisted virtual reality expose therapy (VRET) Market Segmentation by Technology Augmented Reality (AR) Virtual Reality (VR) Market Segmentation by ...

February 2018 141 pages

United States Non-Invasive Prenatal Testing (NIPT) Market Analysis (Actual and Potential), By Pregnancy Risk Level (High & Average Risk), Major Deals, Reimbursement, Key Company Profiles & Demand Forecasts to 2018 - 2023

US$ 1,050.00

... market in the Non-Invasive Prenatal Testing(NIPT) industry United States Non-Invasive Prenatal Testing(NIPT) is expected to register a faster value growth during 2018 - 2023 The Potential United States Non-Invasive Prenatal Testing(NIPT) Market is set ...

February 2018 140 pages

Global Radiation Therapy Market: Industry Analysis & Outlook (2018-2022)

US$ 900.00

... . However, the expansion of radiation therapy market is hindered by stringent regulations, barriers to implementation and harsh side effects of radiation therapy. The report “Global Radiation Therapy Market: Industry Analysis & Outlook (2018 ...

February 2018 110 pages

North America and Europe Acinetobacter Infections Treatment Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... THE REPORT: This report focuses on the Acinetobacter Infections Treatment in North America and Europe market, especially in United States, United ... to deeply display the North America and Europe Acinetobacter Infections Treatment market. Chapter 1, to describe Acinetobacter Infections Treatment Introduction, ...

February 2018 101 pages

North America and Europe Titanium Dental Implants Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... OF THE REPORT: This report focuses on the Titanium Dental Implants in North America and Europe market, especially in United States, United Kingdom, ... Chapters to deeply display the North America and Europe Titanium Dental Implants market. Chapter 1, to describe Titanium Dental Implants Introduction, product type ...

February 2018 108 pages

North America and Europe Tyrosine Kinase JAK Inhibitors Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... THE REPORT: This report focuses on the Tyrosine Kinase JAK Inhibitors in North America and Europe market, especially in United States, United ... Chapters to deeply display the North America and Europe Tyrosine Kinase JAK Inhibitors market. Chapter 1, to describe Tyrosine Kinase JAK Inhibitors Introduction, ...

February 2018 101 pages

North America and Europe UV Infection Control Device Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... : This report focuses on the UV Infection Control Device in North America and Europe market, especially in United States, United Kingdom, Canada, Germany ... Hospital Clinic Others There are 19 Chapters to deeply display the North America and Europe UV Infection Control Device market. Chapter 1, to describe UV ...

February 2018 100 pages

North America and Europe Venous Stents Market by Manufacturers, Regions, Type and Application, Forecast to 2023

US$ 4,480.00

... SCOPE OF THE REPORT: This report focuses on the Venous Stents in North America and Europe market, especially in United States, United Kingdom, Canada ... 19 Chapters to deeply display the North America and Europe Venous Stents market. Chapter 1, to describe Venous Stents Introduction, product type and application ...

February 2018 103 pages

US Ambulatory Electrocardiography (ECG) Market: Industry Analysis & Outlook (2018-2022)

US$ 800.00

... outpatient telemetry (MCOT) and implantable loop recorders. The US ambulatory ECG market is set to experience favorable growth driven by factors such rising ... regulations and high barriers to entry. The report “The US Ambulatory ECG Market: Industry Analysis & Outlook (2018-2022)” analyses the development of ...

February 2018 77 pages

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market: Industry Analysis & Outlook (2018-2025)

US$ 800.00

PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) ... further growth of PARP inhibitor market with upcoming PARP inhibitors and growing cases of cancer. The global PARP inhibitor market is ...

February 2018 80 pages

Global Endometriosis Market: Industry Analysis & Outlook (2018-2025)

US$ 600.00

... drug costs. The report “Global Endometriosis Market: Industry Analysis & Outlook (2018-2025)” analyzes the development of this market. The major trends, growth ... and strategies for growth. The report contains a comprehensive analysis of the global endometriosis market along with the study of the regional ...

February 2018 67 pages

APAC HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025

US$ 2,500.00

... reaction (PCR) segment is expected to dominate the Asia-Pacific HLA typing transplant diagnostics services market with 58.2% market share and is expected ... 2018, hospitals segment is expected to dominate the Asia-Pacific HLA typing transplant diagnostics services market with 53.9% market share and is expected ...

February 2018 102 pages

Asia Pacific Hemodialysis and Peritoneal dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... The Asia Pacific hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis ... of 8.2% in the forecast period 2018 to 2025. The Asia Pacific hemodialysis & peritoneal dialysis market is segmented on the basis of end-user into ...

February 2018 515 pages

Asia-Pacific Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... . The Asia-Pacific anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the Asia-Pacific anti-nuclear antibody test market with 53.0% market share ...

February 2018 248 pages

Europe Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... . The Europe anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the Europe anti-nuclear antibody test market with 59.9% market share ...

February 2018 248 pages

Europe Hemodialysis and Peritoneal Dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... are further sub-segmented into peritoneal dialysis and home dialysis. Based on geography, the Europe hemodialysis & peritoneal dialysis market is segmented into geographical ... present scenario and the growth prospects of the Europe hemodialysis & peritoneal dialysis market for 2018-2025. To calculate the market ...

February 2018 515 pages

Europe HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025

US$ 2,500.00

... chain reaction (PCR) segment is expected to dominate the Europe HLA typing transplant diagnostics services market with 61.8% market share and is expected to ... In 2018, hospitals segment is expected to dominate the Europe HLA typing transplant diagnostics services market with 53.0% market share and is expected to ...

February 2018 101 pages

Global Anti-Nuclear Antibody Test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 4,200.00

... . The global anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, Indirect Immunofluorescence is expected to dominate the global anti-nuclear antibody test market with 53.3% market share ...

February 2018 248 pages

Global Hemodialysis and Peritoneal Dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 4,200.00

... -user The global hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis Market is ... East and Africa. Based on geography, the Global hemodialysis & peritoneal dialysis market is segmented into geographical regions, such as, ...

February 2018 515 pages

Global HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025

US$ 4,200.00

... polymerase chain reaction (PCR) is expected to dominate the global HLA typing transplant diagnostics services market with 57.2% market share and is expected ... In 2018, hospitals segment is expected to dominate the global HLA typing transplant diagnostics services market with 46.4% market share and is expected ...

February 2018 181 pages

North America Anti-Nuclear antibody test Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... North America anti-nuclear antibody test market is segmented on the basis of test into indirect immunofluorescence, ELISA, and multiplex testing. In 2018, indirect immunofluorescence is expected to dominate the North America anti-nuclear antibody test ... , the North America anti-nuclear antibody test market is ...

February 2018 248 pages

North America Hemodialysis and Peritoneal Dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

US$ 2,500.00

... North America hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis Market ... of 7.4% in the forecast period 2018 to 2025. The North America hemodialysis & peritoneal dialysis market is segmented on the basis of end-user ...

February 2018 515 pages

North America HLA Typing Transplant Diagnostics Services Market - Industry Trends Forecast to 2025

US$ 2,500.00

... chain reaction (PCR) segment is expected to dominate the North America HLA typing transplant diagnostics services market with 52.0% market share and is ... In 2018, hospitals segment is expected to dominate the North America HLA typing transplant diagnostics services market with 37.8% market share and is expected ...

February 2018 84 pages

Filters

Search

Categories

538
403
239
22
112,574
57
23,409
8,492
379
94
675
84
1,064
4
507
19
245
238
547
552
304
23
177
38
35,142
40
137
353
700
1,140
23
152
67
3,840
94
1,831
167
48
818
116
1,152
910
657
547
1,865
4,251
1,151
70
509
48,562
94

Publishers

251
21
1
698
53
123
247
4
204
62
273
2
1,105
79
68
584
106
4,452
6,889
30,350
501
2,826
5,841
1
3
1
1
484
7
1,083
7,606
450
142
448
1
2,189
1
136
9
1,696
8
29
79
6
2
75
11,736
2,817
692
6
10,807
171
1
321
1,601
1
33,621
484
66
5
5
214
2
1,360
5,810
151
56
481
149
148
214
3,604
3
4
536
197
15
23
3
107
22
19,652
31
31
1
16
89
9,602
54
146
74
807
1
1,261
2,133
48
220
29
5
11,194
2
45
173
10
111
5
488
11
33
21
160
348
36
110
436
2
89
186
8
313
5
3
393
4
118
58
53
61
8
20
123
111
2
1
2,282
1
13
10
5
492
1
1
15
1
47
3
28
7
3
1
214
7
1
306
6
371
3
290
51
45,182
140
1
2
4
114
2
16
9
43
26
1
212
3
9
4
22
1
2,785
3,792
1
2
3
221
400
78
689
1,004
388
206
160
8
47
32
328
37
4
1,404
7

Regions

247
231
217
216
215
200
199
197
196
156
154
140
140
140
136
136
131
19
18
17
17
15
11
10
7
6
5
5
4
4
4
3
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1,634
1,544
1,398
1,378
1,364
1,364
354
343
309
300
299
297
289
288
288
287
285
282
280
279
279
278
278
277
274
273
273
272
268
267
262
262
260
259
255
253
253
252
252
243
226
226
221
203
197
191
190
181
163
161
67
47
33
26
14
251
198
250
257
6,409
39
170
2
134
131
5,384
308
285
278
7,439
3,586
412
198
115
184,337
208
191
195
474
470
309
287
279
249
166
186
32
184
166
165
17
154
32
238
47
4,813
4,285
8,007

Price

Date

Pages

Offers

265
108
1
391
7
5
17